BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 12499617)

  • 1. Effect of intracoronary nicorandil administration on preventing no-reflow/slow flow phenomenon during rotational atherectomy.
    Tsubokawa A; Ueda K; Sakamoto H; Iwase T; Tamaki S
    Circ J; 2002 Dec; 66(12):1119-23. PubMed ID: 12499617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention of no-reflow/slow-flow phenomenon during rotational atherectomy--a prospective randomized study comparing intracoronary continuous infusion of verapamil and nicorandil.
    Matsuo H; Watanabe S; Watanabe T; Warita S; Kojima T; Hirose T; Iwama M; Ono K; Takahashi H; Segawa T; Minatoguchi S; Fujiwara H
    Am Heart J; 2007 Nov; 154(5):994.e1-6. PubMed ID: 17967610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the effects of nicorandil versus verapamil on the incidence of slow flow/no reflow during rotational atherectomy.
    Iwasaki K; Samukawa M; Furukawa H
    Am J Cardiol; 2006 Nov; 98(10):1354-6. PubMed ID: 17134628
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nicardipine and adenosine "flush cocktail" to prevent no-reflow during rotational atherectomy.
    Fischell TA; Haller S; Pulukurthy S; Virk IS
    Cardiovasc Revasc Med; 2008; 9(4):224-8. PubMed ID: 18928946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cocktail attenuation of rotational ablation flow effects (CARAFE) study: pilot.
    Cohen BM; Weber VJ; Blum RR; Ruck BE; Cohen DE; Haik BJ; Coletti RH
    Cathet Cardiovasc Diagn; 1996; Suppl 3():69-72. PubMed ID: 8874932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The no-reflow phenomenon and its clinical significance].
    Sidorenko GI; OstrovskiÄ­ IuP
    Kardiologiia; 2002; 42(5):74-80. PubMed ID: 12494153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intracoronary adenosine administered during rotational atherectomy of complex lesions in native coronary arteries reduces the incidence of no-reflow phenomenon.
    Hanna GP; Yhip P; Fujise K; Schroth GW; Rosales OR; Anderson HV; Smalling RW
    Catheter Cardiovasc Interv; 1999 Nov; 48(3):275-8. PubMed ID: 10525227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical outcomes of nicorandil administration in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a systematic review and meta-analysis of randomized controlled trials.
    Geng N; Ren L; Xu L; Zou D; Pang W
    BMC Cardiovasc Disord; 2021 Oct; 21(1):488. PubMed ID: 34629058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The effect on myocardial perfusion and clinical outcome of intracoronary nicorandil injection prior to percutaneous coronary intervention in ST-segment elevation myocardial infarction].
    Wang ZQ; Chen MX; Liu DL; Zheng WX; Cao XZ; Chen H; Huang MF; Luo ZR
    Zhonghua Xin Xue Guan Bing Za Zhi; 2017 Jan; 45(1):26-33. PubMed ID: 28100342
    [No Abstract]   [Full Text] [Related]  

  • 10. Prevention of no flow/slow reflow phenomenon in primary PCI by Nicorandil.
    J E; Juneja MS; George T; Sr R; V V; Ak B; Kalyani S; Pandurangi UM; Latchumanadhas K; S MA
    Indian Heart J; 2007; 59(3):246-9. PubMed ID: 19124934
    [TBL] [Abstract][Full Text] [Related]  

  • 11. REstoration of COronary flow in patients with no-reflow after primary coronary interVEntion of acute myocaRdial infarction (RECOVER).
    Huang D; Qian J; Ge L; Jin X; Jin H; Ma J; Liu Z; Zhang F; Dong L; Wang X; Yao K; Ge J
    Am Heart J; 2012 Sep; 164(3):394-401. PubMed ID: 22980307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravenous nicorandil can preserve microvascular integrity and myocardial viability in patients with reperfused anterior wall myocardial infarction.
    Ito H; Taniyama Y; Iwakura K; Nishikawa N; Masuyama T; Kuzuya T; Hori M; Higashino Y; Fujii K; Minamino T
    J Am Coll Cardiol; 1999 Mar; 33(3):654-60. PubMed ID: 10080465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nicorandil Versus Nitroglycerin for Symptomatic Relief of Angina in Patients With Slow Coronary Flow Phenomenon: A Randomized Clinical Trial.
    Sani HD; Eshraghi A; Nezafati MH; Vojdanparast M; Shahri B; Nezafati P
    J Cardiovasc Pharmacol Ther; 2015 Jul; 20(4):401-6. PubMed ID: 25701829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Utility of nicorandil for the measurement of coronary fractional flow reserve.
    Oi M; Toyofuku M; Matsumura Y; Motohashi Y; Takahashi K; Kawase Y; Ko E; Tanaka M; Kitada M; Yuzuki Y; Tamura T; Tanaka N; Kimura T
    Cardiovasc Interv Ther; 2014 Jan; 29(1):24-30. PubMed ID: 24002893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Coronary rotational atherectomy: initial experience at a hospital without a special department for heart surgery].
    Belli R; De Benedictis M; Varbella F; Castello V; Baduini G
    G Ital Cardiol; 1996 Jul; 26(7):765-74. PubMed ID: 8964319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of intracoronary adenosine and isosorbide dinitrate on no-reflow/slow flow during rotational atherectomy.
    Tsao TP; Cheng SM; Cheng CC; Yang SP
    Acta Cardiol; 2009 Apr; 64(2):225-30. PubMed ID: 19476116
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of combined intracoronary adenosine and nicorandil on no-reflow phenomenon during percutaneous coronary intervention.
    Lim SY; Bae EH; Jeong MH; Kang DG; Lee YS; Kim KH; Lee SH; Yoon KH; Hong SN; Park HW; Hong YJ; Kim JH; Kim W; Ahn YK; Cho JG; Park JC; Kang JC
    Circ J; 2004 Oct; 68(10):928-32. PubMed ID: 15459466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disappearance of the 'no-reflow' phenomenon after adjunctive intracoronary administration of nicorandil in a patient with acute myocardial infarction.
    Sakata Y; Kodama K; Ishikura F; Komamura K; Hasegawa S; Sakata Y; Hirayama A
    Jpn Circ J; 1997 May; 61(5):455-8. PubMed ID: 9192246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of no-reflow in degenerated saphenous vein graft interventions: comparison of intracoronary verapamil and nitroglycerin.
    Kaplan BM; Benzuly KH; Kinn JW; Bowers TR; Tilli FV; Grines CL; O'Neill WW; Safian RD
    Cathet Cardiovasc Diagn; 1996 Oct; 39(2):113-8. PubMed ID: 8922307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the effects of nitroprusside versus nicorandil on the slow/no-reflow phenomenon during coronary interventions for acute myocardial infarction.
    Kobatake R; Sato T; Fujiwara Y; Sunami H; Yoshioka R; Ikeda T; Saito H; Ujihira T
    Heart Vessels; 2011 Jul; 26(4):379-84. PubMed ID: 21110199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.